BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Alkeus Pharmaceuticals Receives FDA Rare Pediatric Disease and Fast Track Designations for Gildeuretinol as a Treatment for Stargardt Disease

  November 18, 2024

   · 

  6 min read
• Press Releases

  CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)

  November 18, 2024

   · 

  1 min read
• Press Releases

  Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

  November 18, 2024

   · 

  9 min read
• Press Releases

  Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

  Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study Episodes of pericarditis per year substantially reduced MAvERIC-Pilot results support advancing CardiolRx™ into the Phase II/III MAVERIC-2 and the Phase III MAVERIC-3 clinical trials

  November 18, 2024

   · 

  11 min read
• Press Releases

  Introducing the New Sciospec Software Suite for Impedance Measurements

  November 18, 2024

   · 

  5 min read
• Press Releases

  Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

  November 18, 2024

   · 

  6 min read
• Press Releases

  LIfT BioSciences expands into Ireland for manufacturing & clinical operations

  November 18, 2024

   · 

  5 min read
• Press Releases

  AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer

  November 18, 2024

   · 

  13 min read
• Press Releases

  UK Regulator MHRA Grants Nanomerics Clinical Trials Authorisation Notice for its Upcoming OC134 Clinical Trial

  November 18, 2024

   · 

  2 min read
• Press Releases

  EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome

  November 18, 2024

   · 

  4 min read